Elisabeth Svensson | Future Pharma

Future Pharma 2026

June 1 - 2, 2026

Renaissance Seaport District, Boston, MA

Elisabeth Svensson

Elisabeth Svensson

Vice President Global Industry Leader, Health Group Aquent Studios

Redefining Engagement: Trust, Technology, and Transformation

1:40 PM Workshop: Inside a $250M Pharma Content Transformation: Scaling Content Without Scaling Complexity

This session will provide commercial leaders with a practical framework for accelerating strategic initiatives by aligning workforce strategy with business priorities—unlocking both operational agility and creative excellence. You'll learn how to optimize workforce models, elevate brand execution, and deliver differentiated customer experiences at scale.

Content transformation is often framed as a production problem: make more assets, move faster, add tools, automate the work. But that misses the real issue. At enterprise scale, content transformation is an operating model problem.

In this fireside chat, Jason Boyer, SVP at Aquent Studios and former CMO of Deloitte, will speak with Elisabeth Svensson about lessons from a large pharma content transformation tied to more than $250M in projected content production spend and expected to reduce annual production costs by roughly $40M.

The conversation will explore how the work started with data to reveal where cost, duplication, rework, review friction, and global to local complexity were being created. Jason and Elisabeth will unpack why the answer was not simply to implement new technology or AI, and rather to bring the client's global content leaders together through a facilitated, in-person, design thinking lab to align on the real problem, establish a shared language, define modular content principles, clarify decision rights, agree on success metrics, and shape a pilot to prove the model before scaling globally. 

Check out the incredible speaker line-up to see who will be joining Elisabeth.

Download The Latest Agenda